|
|
immune effector process
|
GO:0002252 |
321 |
0.698
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.599
|
|
|
|
regulation of defense response to virus
|
GO:0050688 |
18 |
0.598
|
|
|
|
cellular response to interferon alpha
|
GO:0035457 |
4 |
0.589
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.558
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.497
|
|
|
|
cellular response to interferon beta
|
GO:0035458 |
21 |
0.423
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.391
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.361
|
Human |
|
|
viral process
|
GO:0016032 |
41 |
0.339
|
Human |
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.328
|
|
|
|
regulation of defense response to virus by host
|
GO:0050691 |
8 |
0.301
|
|
|
|
regulation of nlrp3 inflammasome complex assembly
|
GO:1900225 |
4 |
0.298
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.283
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.258
|
|
|
|
negative regulation of nlrp3 inflammasome complex assembly
|
GO:1900226 |
2 |
0.241
|
|
|
|
cd8 positive alpha beta t cell proliferation
|
GO:0035740 |
1 |
0.239
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.238
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.235
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.222
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.217
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.214
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.213
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.190
|
Human |
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
4 |
0.188
|
|
|
|
negative regulation of toll like receptor signaling pathway
|
GO:0034122 |
14 |
0.180
|
|
|
|
regulation of myd88 independent toll like receptor signaling pathway
|
GO:0034127 |
1 |
0.180
|
|
|
|
positive regulation of viral genome replication
|
GO:0045070 |
2 |
0.177
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.170
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.165
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.164
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.162
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.155
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.153
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.152
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.144
|
|
|
|
regulation of actin nucleation
|
GO:0051125 |
4 |
0.143
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.140
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.140
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.140
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.135
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.135
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.134
|
|
|
|
positive regulation of t cell mediated cytotoxicity
|
GO:0001916 |
15 |
0.130
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.129
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.127
|
|
|
|
toll like receptor 7 signaling pathway
|
GO:0034154 |
4 |
0.125
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.123
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.120
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.119
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.118
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.117
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.116
|
|
|
|
regulation of interferon beta production
|
GO:0032648 |
13 |
0.115
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.113
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.112
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.108
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.107
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.107
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.105
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.105
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.104
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.104
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.103
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.102
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.102
|
Human |
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.100
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.098
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.094
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.093
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.091
|
|
|
|
positive regulation of actin nucleation
|
GO:0051127 |
3 |
0.091
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.091
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.091
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.091
|
|
|
|
positive regulation of viral entry into host cell
|
GO:0046598 |
3 |
0.090
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.087
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.086
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.084
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.083
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.083
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.082
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.082
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.082
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.080
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.080
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.077
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.077
|
|
|
|
interferon beta production
|
GO:0032608 |
16 |
0.077
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.077
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.076
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.076
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.075
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.074
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.074
|
|
|
|
positive regulation of rig i signaling pathway
|
GO:1900246 |
1 |
0.074
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.074
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.074
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.073
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.073
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.072
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.072
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.072
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.071
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.071
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.071
|
|
|
|
interferon beta biosynthetic process
|
GO:0045350 |
4 |
0.071
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.070
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.070
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.069
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.069
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.069
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.068
|
|
|
|
positive regulation of type i interferon mediated signaling pathway
|
GO:0060340 |
4 |
0.067
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.066
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.066
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.065
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.065
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.064
|
|
|
|
negative regulation of viral process
|
GO:0048525 |
23 |
0.063
|
Human |
|
|
response to interferon beta
|
GO:0035456 |
22 |
0.063
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.063
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.062
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.062
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.062
|
|
|
|
viral genome replication
|
GO:0019079 |
17 |
0.062
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.061
|
Human |
|
|
regulation of interferon beta biosynthetic process
|
GO:0045357 |
4 |
0.061
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.060
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.060
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.060
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.059
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.059
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.059
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.057
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.057
|
Human |
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.056
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.056
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.056
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.055
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.055
|
|
|
|
regulation of cd8 positive alpha beta t cell proliferation
|
GO:2000564 |
1 |
0.055
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.055
|
|
|
|
response to interferon alpha
|
GO:0035455 |
7 |
0.054
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.054
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.054
|
Human |
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.054
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.053
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.052
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.052
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.052
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.052
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.051
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.051
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.051
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.051
|
|
|
|
regulation of cd8 positive alpha beta t cell activation
|
GO:2001185 |
3 |
0.051
|
|
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
20 |
0.051
|
|
|
|
regulation of rig i signaling pathway
|
GO:0039535 |
2 |
0.051
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.050
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.050
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.049
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.048
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.047
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.047
|
|
|
|
negative regulation of defense response to virus by host
|
GO:0050689 |
1 |
0.047
|
|
|
|
entry into cell of other organism involved in symbiotic interaction
|
GO:0051806 |
15 |
0.047
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.046
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.046
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.045
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.045
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.045
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.045
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.045
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.044
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.044
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.044
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.043
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.043
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.043
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.043
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.042
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.042
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.042
|
Human |
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.042
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.042
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.041
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.041
|
|
|
|
positive regulation of interferon gamma production
|
GO:0032729 |
39 |
0.041
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.040
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.040
|
Human |
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.040
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.040
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.040
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.039
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.039
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.039
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.038
|
|
|
|
negative regulation of viral release from host cell
|
GO:1902187 |
6 |
0.038
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.038
|
|
|
|
positive t cell selection
|
GO:0043368 |
23 |
0.037
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.037
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.036
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.036
|
Human |
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.036
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.036
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.035
|
Human |
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.035
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.035
|
|
|
|
natural killer cell mediated cytotoxicity
|
GO:0042267 |
29 |
0.035
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.035
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.035
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.035
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.035
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.035
|
Human |
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.034
|
|
|
|
positive regulation of actin filament polymerization
|
GO:0030838 |
26 |
0.034
|
|
|
|
rig i signaling pathway
|
GO:0039529 |
4 |
0.034
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.034
|
|
|
|
positive regulation of t cell mediated immunity
|
GO:0002711 |
24 |
0.034
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.034
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.034
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.034
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.034
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.034
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.033
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.033
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.033
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.032
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.032
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.032
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.031
|
|
|
|
natural killer cell proliferation
|
GO:0001787 |
3 |
0.031
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.031
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.031
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.031
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.031
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.031
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.031
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
3 |
0.031
|
Human |
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.030
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.030
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.030
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.030
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.030
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.030
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.030
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.030
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.030
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.030
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.029
|
|
|
|
negative regulation of viral genome replication
|
GO:0045071 |
10 |
0.029
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.029
|
Human |
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.029
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.029
|
Mouse |
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.029
|
|
|
|
regulation of myd88 dependent toll like receptor signaling pathway
|
GO:0034124 |
2 |
0.029
|
|
|
|
regulation of natural killer cell activation
|
GO:0032814 |
22 |
0.029
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.029
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.029
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.029
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.028
|
|
|
|
viral life cycle
|
GO:0019058 |
36 |
0.028
|
Human |
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.028
|
|
|
|
lipopolysaccharide mediated signaling pathway
|
GO:0031663 |
25 |
0.028
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.028
|
|
|
|
negative regulation of viral entry into host cell
|
GO:0046597 |
10 |
0.028
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.028
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.028
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.028
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.028
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.028
|
|
|
|
negative regulation of interferon beta production
|
GO:0032688 |
3 |
0.027
|
|
|
|
regulation of viral induced cytoplasmic pattern recognition receptor signaling pathway
|
GO:0039531 |
2 |
0.027
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.027
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.027
|
|
|
|
regulation of type i interferon mediated signaling pathway
|
GO:0060338 |
7 |
0.027
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.027
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.027
|
Mouse |
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.027
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.027
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.027
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.027
|
|
|
|
defense response to protozoan
|
GO:0042832 |
25 |
0.027
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.027
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.026
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.026
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.026
|
|
|
|
negative regulation of response to biotic stimulus
|
GO:0002832 |
10 |
0.026
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.026
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.026
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.026
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.026
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.026
|
|
|
|
regulation of natural killer cell mediated cytotoxicity
|
GO:0042269 |
19 |
0.026
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.026
|
|
|
|
regulation of t cell mediated cytotoxicity
|
GO:0001914 |
18 |
0.026
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.026
|
Mouse |
|
|
negative regulation of interferon beta biosynthetic process
|
GO:0045358 |
1 |
0.025
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.025
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.025
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.025
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.024
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.024
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.024
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.024
|
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
25 |
0.024
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.024
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.024
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.024
|
Human |
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.024
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.024
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.024
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.023
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.023
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.023
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.023
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.023
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.023
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.023
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.023
|
|
|
|
antigen processing and presentation of endogenous peptide antigen via mhc class ib
|
GO:0002476 |
4 |
0.023
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.023
|
Human |
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.023
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.023
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.023
|
Human |
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.022
|
|
|
|
t cell selection
|
GO:0045058 |
34 |
0.022
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.022
|
|
|
|
alpha beta t cell proliferation
|
GO:0046633 |
21 |
0.022
|
|
|
|
type i interferon production
|
GO:0032606 |
29 |
0.022
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.022
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
22 |
0.022
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.022
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.022
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.022
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.022
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.022
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.022
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.022
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.022
|
|
|
|
regulation of viral genome replication
|
GO:0045069 |
13 |
0.022
|
|
|
|
nuclear membrane organization
|
GO:0071763 |
4 |
0.021
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.021
|
|
|
|
type i interferon signaling pathway
|
GO:0060337 |
10 |
0.021
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.021
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.021
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.021
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.021
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.021
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.021
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.021
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.021
|
Human |
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.021
|
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.021
|
Human |
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.021
|
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.020
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.020
|
Human |
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.020
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.020
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.020
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.020
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.020
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.020
|
|
|
|
negative regulation of regulatory t cell differentiation
|
GO:0045590 |
2 |
0.020
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.020
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.020
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.020
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.020
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.020
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.020
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.020
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.020
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.020
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.019
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.019
|
Human |
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.019
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.019
|
|
|
|
citrate metabolic process
|
GO:0006101 |
3 |
0.019
|
|
|
|
cytoplasmic pattern recognition receptor signaling pathway in response to virus
|
GO:0039528 |
4 |
0.019
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.019
|
Human |
|
|
olfactory bulb interneuron differentiation
|
GO:0021889 |
12 |
0.019
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.019
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.019
|
|
|
|
hair follicle cell proliferation
|
GO:0071335 |
3 |
0.019
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.019
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.018
|
|
|
|
interaction with host
|
GO:0051701 |
22 |
0.018
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.018
|
Human |
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
45 |
0.018
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.018
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.018
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.018
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.018
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.018
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.018
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.018
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.018
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.017
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.017
|
Human |
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.017
|
Human |
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.017
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.017
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.017
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.017
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.017
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.017
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.017
|
|
|
|
alpha beta t cell differentiation involved in immune response
|
GO:0002293 |
30 |
0.017
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.017
|
|
|
|
negative regulation of leukocyte mediated immunity
|
GO:0002704 |
29 |
0.017
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.017
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.017
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.016
|
|
|
|
positive regulation of type i interferon production
|
GO:0032481 |
14 |
0.016
|
|
|
|
negative regulation of viral transcription
|
GO:0032897 |
3 |
0.016
|
Human |
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.016
|
|
|
|
positive regulation of t cell receptor signaling pathway
|
GO:0050862 |
4 |
0.016
|
|
|
|
regulation of viral release from host cell
|
GO:1902186 |
6 |
0.016
|
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.016
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.016
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.016
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.016
|
|
|
|
mast cell proliferation
|
GO:0070662 |
4 |
0.016
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.016
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.016
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.016
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.016
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.015
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.015
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.015
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.015
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.015
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.015
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.015
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.015
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.015
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.015
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.015
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.015
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.015
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.015
|
|
|
|
positive regulation of rac gtpase activity
|
GO:0032855 |
14 |
0.015
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.015
|
Human |
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.015
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.015
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.015
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.015
|
|
|
|
cellular response to type i interferon
|
GO:0071357 |
10 |
0.015
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.015
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.015
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.015
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.015
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.015
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.015
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.015
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.014
|
|
|
|
alpha beta t cell activation involved in immune response
|
GO:0002287 |
31 |
0.014
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.014
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.014
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.014
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.014
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.014
|
|
|
|
negative regulation of defense response to virus
|
GO:0050687 |
6 |
0.014
|
|
|
|
myd88 independent toll like receptor signaling pathway
|
GO:0002756 |
3 |
0.014
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.014
|
|
|
|
t cell lineage commitment
|
GO:0002360 |
13 |
0.014
|
|
|
|
cd8 positive alpha beta t cell differentiation
|
GO:0043374 |
9 |
0.014
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.014
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.014
|
|
|
|
positive regulation of leukocyte mediated cytotoxicity
|
GO:0001912 |
31 |
0.014
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.014
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.014
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.014
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.014
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.014
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.014
|
|
|
|
natural killer cell mediated immunity
|
GO:0002228 |
29 |
0.013
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.013
|
Human |
|
|
negative regulation of binding
|
GO:0051100 |
39 |
0.013
|
Human |
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.013
|
|
|
|
regulation of myeloid dendritic cell activation
|
GO:0030885 |
5 |
0.013
|
|
|
|
iron ion import into cell
|
GO:0097459 |
4 |
0.013
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.013
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.013
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.013
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.013
|
|
|
|
cd4 positive alpha beta t cell lineage commitment
|
GO:0043373 |
6 |
0.013
|
|
|
|
response to dsrna
|
GO:0043331 |
30 |
0.013
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.013
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.013
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.013
|
|
|
|
entry into other organism involved in symbiotic interaction
|
GO:0051828 |
15 |
0.013
|
|
